Identifying replicable healthcare models with significant social benefit

On behalf of GlaxoSmithKline (GSK) in 2013, we produced this report that assesses over 900 healthcare programmes for their suitability for investment to scale up and replicate elsewhere. It identifies significant opportunities for commercial organisations to establish strategic partnerships with a number of promising healthcare delivery models in order to drive scale, profitability and impact.

Press:

• Big Business and Healthcare: It’s not about the money – Andy Thornton for Stanford Social Innovation Review 
• Where is the BoP healthcare fortune? – Andy Thornton for Stanford Social Innovation Review
• How to take projects to scale in developing countries – Dan Berelowitz for The Guardian 

  *In 2017 The International Centre for Social Franchising (ICSF) became Spring Impact. This report was created under our old      branding and name.